Amelioration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced behavioural dysfunction and oxidative stress by Pycnogenol in mouse model of Parkinson's disease

Mohammad Moshahid Khan, MD Nasrul Hoda, Tauheed Ishrat, Ajmal Ahmad, Mohammad Badruzzaman Khan, Gulrana Khuwaja, Syed Shadab Raza, Mohammed M. Safhi, Fakhrul Islam

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Increased oxidative stress is implicated in the pathogenesis of Parkinson's disease in which dopaminergic neurons are intrinsically susceptible to oxidative damage. Swiss albino mice were pretreated with Pycnogenol (PYC), an extract of Pinus maritime bark [20(mg/kg body weight, intraperitoneally (i.p.)] once daily for 15 days. Thereafter, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) (20(mg/kg body weight, intraperitoneally) was given four times at 2-hour intervals on 1 day only. Behaviours were altered in the MPTP group as compared with the vehicle-treated group and were restored in the PYC-pretreated MPTP group. The activity of antioxidant enzymes and the content of glutathione were significantly depleted in the MPTP-induced Parkinsonian group. The MPTP group pretreated with PYC showed significant protection of the activity of antioxidant enzymes and glutathione content when compared with the vehicle-treated MPTP group. A significantly elevated level of thiobarbituric acid reactive substances in the MPTP group was decreased significantly in the animals pretreated with PYC. An increase in the number of dopaminergic D2 receptors and decrease in the level of dopamine and its metabolite 3,4-dihydroxyphenyl acetic acid in the striatum were observed after MPTP injection, and restored significantly after PYC pretreatment. Thus, PYC may be used to prevent or reduce the deterioration caused by free radicals, thereby preventing subsequent behavioural and biochemical changes that occur in Parkinsonian mice.

Original languageEnglish (US)
Pages (from-to)563-571
Number of pages9
JournalBehavioural Pharmacology
Volume21
Issue number5-6
DOIs
StatePublished - Sep 1 2010

Fingerprint

1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine
Parkinson Disease
Oxidative Stress
Glutathione
Antioxidants
Body Weight
Pinus
Thiobarbituric Acid Reactive Substances
Dopaminergic Neurons
Enzymes
pycnogenols
4-phenyl-1,2,3,6-tetrahydropyridine
Acetic Acid
Free Radicals
Dopamine
Injections

Keywords

  • Antioxidant enzymes
  • MPTP
  • Parkinsonism
  • Pycnogenol
  • free radicals

ASJC Scopus subject areas

  • Pharmacology
  • Psychiatry and Mental health

Cite this

Amelioration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced behavioural dysfunction and oxidative stress by Pycnogenol in mouse model of Parkinson's disease. / Khan, Mohammad Moshahid; Hoda, MD Nasrul; Ishrat, Tauheed; Ahmad, Ajmal; Khan, Mohammad Badruzzaman; Khuwaja, Gulrana; Raza, Syed Shadab; Safhi, Mohammed M.; Islam, Fakhrul.

In: Behavioural Pharmacology, Vol. 21, No. 5-6, 01.09.2010, p. 563-571.

Research output: Contribution to journalArticle

Khan, Mohammad Moshahid ; Hoda, MD Nasrul ; Ishrat, Tauheed ; Ahmad, Ajmal ; Khan, Mohammad Badruzzaman ; Khuwaja, Gulrana ; Raza, Syed Shadab ; Safhi, Mohammed M. ; Islam, Fakhrul. / Amelioration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced behavioural dysfunction and oxidative stress by Pycnogenol in mouse model of Parkinson's disease. In: Behavioural Pharmacology. 2010 ; Vol. 21, No. 5-6. pp. 563-571.
@article{168cb579f4e642cb9e012d65e06137f3,
title = "Amelioration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced behavioural dysfunction and oxidative stress by Pycnogenol in mouse model of Parkinson's disease",
abstract = "Increased oxidative stress is implicated in the pathogenesis of Parkinson's disease in which dopaminergic neurons are intrinsically susceptible to oxidative damage. Swiss albino mice were pretreated with Pycnogenol (PYC), an extract of Pinus maritime bark [20(mg/kg body weight, intraperitoneally (i.p.)] once daily for 15 days. Thereafter, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) (20(mg/kg body weight, intraperitoneally) was given four times at 2-hour intervals on 1 day only. Behaviours were altered in the MPTP group as compared with the vehicle-treated group and were restored in the PYC-pretreated MPTP group. The activity of antioxidant enzymes and the content of glutathione were significantly depleted in the MPTP-induced Parkinsonian group. The MPTP group pretreated with PYC showed significant protection of the activity of antioxidant enzymes and glutathione content when compared with the vehicle-treated MPTP group. A significantly elevated level of thiobarbituric acid reactive substances in the MPTP group was decreased significantly in the animals pretreated with PYC. An increase in the number of dopaminergic D2 receptors and decrease in the level of dopamine and its metabolite 3,4-dihydroxyphenyl acetic acid in the striatum were observed after MPTP injection, and restored significantly after PYC pretreatment. Thus, PYC may be used to prevent or reduce the deterioration caused by free radicals, thereby preventing subsequent behavioural and biochemical changes that occur in Parkinsonian mice.",
keywords = "Antioxidant enzymes, MPTP, Parkinsonism, Pycnogenol, free radicals",
author = "Khan, {Mohammad Moshahid} and Hoda, {MD Nasrul} and Tauheed Ishrat and Ajmal Ahmad and Khan, {Mohammad Badruzzaman} and Gulrana Khuwaja and Raza, {Syed Shadab} and Safhi, {Mohammed M.} and Fakhrul Islam",
year = "2010",
month = "9",
day = "1",
doi = "10.1097/FBP.0b013e32833d4186",
language = "English (US)",
volume = "21",
pages = "563--571",
journal = "Behavioural Pharmacology",
issn = "0955-8810",
publisher = "Lippincott Williams and Wilkins",
number = "5-6",

}

TY - JOUR

T1 - Amelioration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced behavioural dysfunction and oxidative stress by Pycnogenol in mouse model of Parkinson's disease

AU - Khan, Mohammad Moshahid

AU - Hoda, MD Nasrul

AU - Ishrat, Tauheed

AU - Ahmad, Ajmal

AU - Khan, Mohammad Badruzzaman

AU - Khuwaja, Gulrana

AU - Raza, Syed Shadab

AU - Safhi, Mohammed M.

AU - Islam, Fakhrul

PY - 2010/9/1

Y1 - 2010/9/1

N2 - Increased oxidative stress is implicated in the pathogenesis of Parkinson's disease in which dopaminergic neurons are intrinsically susceptible to oxidative damage. Swiss albino mice were pretreated with Pycnogenol (PYC), an extract of Pinus maritime bark [20(mg/kg body weight, intraperitoneally (i.p.)] once daily for 15 days. Thereafter, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) (20(mg/kg body weight, intraperitoneally) was given four times at 2-hour intervals on 1 day only. Behaviours were altered in the MPTP group as compared with the vehicle-treated group and were restored in the PYC-pretreated MPTP group. The activity of antioxidant enzymes and the content of glutathione were significantly depleted in the MPTP-induced Parkinsonian group. The MPTP group pretreated with PYC showed significant protection of the activity of antioxidant enzymes and glutathione content when compared with the vehicle-treated MPTP group. A significantly elevated level of thiobarbituric acid reactive substances in the MPTP group was decreased significantly in the animals pretreated with PYC. An increase in the number of dopaminergic D2 receptors and decrease in the level of dopamine and its metabolite 3,4-dihydroxyphenyl acetic acid in the striatum were observed after MPTP injection, and restored significantly after PYC pretreatment. Thus, PYC may be used to prevent or reduce the deterioration caused by free radicals, thereby preventing subsequent behavioural and biochemical changes that occur in Parkinsonian mice.

AB - Increased oxidative stress is implicated in the pathogenesis of Parkinson's disease in which dopaminergic neurons are intrinsically susceptible to oxidative damage. Swiss albino mice were pretreated with Pycnogenol (PYC), an extract of Pinus maritime bark [20(mg/kg body weight, intraperitoneally (i.p.)] once daily for 15 days. Thereafter, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) (20(mg/kg body weight, intraperitoneally) was given four times at 2-hour intervals on 1 day only. Behaviours were altered in the MPTP group as compared with the vehicle-treated group and were restored in the PYC-pretreated MPTP group. The activity of antioxidant enzymes and the content of glutathione were significantly depleted in the MPTP-induced Parkinsonian group. The MPTP group pretreated with PYC showed significant protection of the activity of antioxidant enzymes and glutathione content when compared with the vehicle-treated MPTP group. A significantly elevated level of thiobarbituric acid reactive substances in the MPTP group was decreased significantly in the animals pretreated with PYC. An increase in the number of dopaminergic D2 receptors and decrease in the level of dopamine and its metabolite 3,4-dihydroxyphenyl acetic acid in the striatum were observed after MPTP injection, and restored significantly after PYC pretreatment. Thus, PYC may be used to prevent or reduce the deterioration caused by free radicals, thereby preventing subsequent behavioural and biochemical changes that occur in Parkinsonian mice.

KW - Antioxidant enzymes

KW - MPTP

KW - Parkinsonism

KW - Pycnogenol

KW - free radicals

UR - http://www.scopus.com/inward/record.url?scp=77955985008&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77955985008&partnerID=8YFLogxK

U2 - 10.1097/FBP.0b013e32833d4186

DO - 10.1097/FBP.0b013e32833d4186

M3 - Article

C2 - 20657266

AN - SCOPUS:77955985008

VL - 21

SP - 563

EP - 571

JO - Behavioural Pharmacology

JF - Behavioural Pharmacology

SN - 0955-8810

IS - 5-6

ER -